Test whether Hericium retains PC12 neurite phenotype under NGF/TrkA block that abolishes NGF-class gain
Hericium erinaceus is often framed through NGF induction or NGF-mediated neurite potentiation, yet human cognition arms lack NGF/TrkA pharmacodynamics and pathway papers do not co-design an abolish-NGF-class / residual-Hericium panel. This discussion asks whether residual Hericium neurite phenotype on PC12 survives NGF neutralization or TrkA blockade that abolishes an NGF-class positive-control gain.
Claim
On a pre-registered PC12 neurite-outgrowth panel with an NGF-class positive control, NGF neutralization or TrkA blockade that abolishes NGF-class neurite gain, and a Hericium erinaceus extract (or named hericenone/erinacine prep) arm: under the same block that abolishes NGF-class neurite gain, Hericium retains residual neurite phenotype ≥50% of Hericium-alone (neurite-bearing % or neurite length units as pre-specified; α/N pre-specified) — assumption-kill / ngf-insufficiency.
Why it matters
Hericium is often framed via NGF induction or NGF-mediated neurite potentiation, but human cognition arms lack NGF/TrkA PD and pathway papers do not co-design abolish-NGF-class / residual-Hericium on one panel. N17 asks whether residual Hericium neurite phenotype survives NGF neutralization or TrkA blockade that kills an NGF-class positive control — ngf-insufficiency assumption-kill. Distinct from N2 (cognition without NGF PD; cell NGF; BDNF≠NGF; open Q block→lose benefit? UNKNOWN — not matched residual H2H; N2 holds sole ip_class=none); N15 ≠ N17 (not modafinil-DAT residual); N16 ≠ N17 (not creatine plasma/PCr); NOT MB/MAOI. Soft-claims: discussion — matched residual-Hericium under NGF/TrkA block that abolishes NGF-class gain H2H UNKNOWN; PRIOR_ART UNKNOWN; soft-complete empty ≠ novelty / ≠ failure; N1–N16 ≠ proof.
Mechanism sketch
Ngf-insufficiency assumption-kill: Hericium extract induces NGF in 1321N1/hippocampus and constituents potentiate NGF-mediated PC12 neurite outgrowth; separate human arms move cognition without NGF PD or block arms. No published head-to-head scores residual Hericium neurite (or cognitive) phenotype under NGF neutralization / TrkA blockade that abolishes an NGF-class positive control on the same panel. Prefer a same-panel PC12 neurite design locking NGF-class positive control ± named TrkA inhibitor or neutralizing NGF Ab vs Hericium extract (or named hericenone/erinacine prep) ± same block before treating NGF/TrkA as necessary for Hericium phenotype; optional rodent cognitive overlay only after cell abolish×residual locks. Optional BDNF overlay (Li) is adjacent only. Competing caveats: block fails to abolish NGF-class gain / Hericium-alone null / underpowered strata / assay-identity mismatch (potentiation or NGF-deprivation survival ≠ residual-under-block) leave the test inconclusive rather than refuted; soft-complete empty ≠ novelty / ≠ residual-gain proof; N2 open Q ≠ this H2H; N15 ≠ this; N16 ≠ this. NOT MB/MAOI (SERIES_FROZEN).
Prior art
- PMID 18844328 / DOI 10.1002/ptr.2634 — Mori: Yamabushitake (Hericium erinaceus) MCI RCT; HDS-R improved vs placebo over 16 weeks, fell after washout — human cognition without NGF PD / no TrkA-block arm; not residual-under-block H2H.
- PMID 18758067 / DOI 10.1248/bpb.31.1727 — Mori/Kawagishi: H. erinaceus extract ↑ NGF mRNA/protein in 1321N1 astrocytes; hippocampal NGF mRNA ↑ in mice; conditioned medium enhanced PC12 neurites; hericenones C/D/E failed NGF gene induction in that assay — cell/animal NGF induction prior; not residual-under-block H2H.
- PMID 32581767 / DOI 10.3389/fnagi.2020.00155 / PMC7283924 — Li: erinacine A–enriched Hericium mycelia mild-AD RCT; MMSE / IADL / neuroimaging; biomarkers include BDNF, Aβ1-40, apoE4, ACT — NGF not listed; no TrkA/NGF-block residual arm; BDNF pathway ≠ NGF mediation / ≠ residual H2H.
- PMID 26481911 / DOI 10.1016/j.bmcl.2015.10.016 — Zhang: Hericium constituents stimulate / potentiate NGF-mediated neurite outgrowth on PC12 (in presence of NGF) — potentiation context prior; not residual under block that abolishes NGF-class gain.
Baseline claimed
Under NGF neutralization or TrkA blockade that abolishes an NGF-class neurite-outgrowth / cognitive positive control, Hericium extract (or named hericenone/erinacine prep) still retains neurite or cognitive phenotype on the same panel — or N2 open Q / N15 modafinil-DAT residual / N16 plasma-Cr/PCr / N1–N16 already settle residual Hericium under NGF/TrkA block.
Baseline measured
Human cognition without NGF PD LITERATURE (PMID 18844328; 32581767). Cell/animal NGF induction LITERATURE (PMID 18758067). PC12 NGF-potentiation LITERATURE (PMID 26481911). Matched residual-Hericium under NGF/TrkA block that abolishes NGF-class neurite/cognitive gain UNKNOWN (soft-complete Hericium∩(TrkA|anti-NGF|K252a|GW441756)∩(neurite|cognition|PC12) = 3 NON-MATCH potentiation/pathway; neutralizing anti-NGF ∩ Hericium = 0; Mori/Li ∩ block residual = 0; MB/MAOI∩Hericium∩(NGF|TrkA|neurite) = 0; modafinil∩DAT∩Hericium = 0; creatine∩(PCr|plasma)∩Hericium = 0). Residual Hericium neurite ≥50% of Hericium-alone when NGF-class gain abolished PREDICTION. N2 ≠ N17; N15 ≠ N17; N16 ≠ N17; N1–N16 ≠ proof — soft-complete empty ≠ novelty / ≠ residual-gain proof.
Actionable limitations
- Do not treat N1–N16 as proving N17 — N2 mapped cognition without NGF PD + cell NGF + BDNF≠NGF and left “block NGF/TrkA → lose benefit?” as open UNKNOWN; that is not a matched residual-under-block H2H; N15 is residual modafinil PVT under DAT-matched block; N16 is plasma-Cr↑ without ³¹P PCr fails SD WM; soft-complete empty ≠ demonstrated residual gain.
- Potentiation / TrkA-pathway ≠ residual-under-block H2H — Zhang 26481911 potentiates NGF-mediated outgrowth; adjacent Zhang 28758954 / Phan 25288148 / Rupcic 33066380 are TrkA/Erk potentiation, partial K252a on hericenone+low-NGF, or TrkA-dependent erinacine C — none co-design NGF-class positive control abolished by the same block while scoring residual Hericium phenotype.
- Human Mori/Li/Saitsu cognition arms lack NGF/TrkA PD and lack block arms; lock same-panel PC12 neurite (prefer cell before animal/human) with NGF-class positive control ± TrkA-i/NGF Ab vs Hericium ± same block; no dosing; NOT MB/MAOI; not N15 DAT clone; not N16 creatine clone; do not burn ip_class=none.
Method
propose-assay
Labels
status_labels: [NEGATIVE] novelty_tag: assumption-kill polarity: negative openlabs_target: discussion openlabs_topic: neuroscience-brain tags: nootropics, brain-longevity risk_class: research-discussion
Prediction variables
| name | kind | assay | threshold |
|---|---|---|---|
| Mori_Yamabushitake_MCI_cognition_without_NGF_PD | LITERATURE | Human MCI RCT; oral Yamabushitake (Hericium erinaceus) fruiting-body powder; HDS-R (Mori 2009) | HDS-R improved vs placebo during 16-week intake; scores fell after washout (PMID 18844328 / DOI 10.1002/ptr.2634) — no NGF PD / no TrkA-block arm; not residual-under-block H2H |
| Mori_Hericium_NGF_induction_1321N1_PC12 | LITERATURE | 1321N1 human astrocytoma + mouse hippocampus NGF induction; PC12 neurite via conditioned medium (Mori/Kawagishi 2008) | H. erinaceus extract ↑ NGF mRNA/protein in 1321N1; hippocampal NGF mRNA ↑ in mice; CM enhanced PC12 neurites; hericenones C/D/E failed NGF gene induction in that assay (PMID 18758067 / DOI 10.1248/bpb.31.1727) — NGF induction prior; not residual-under-block H2H |
| Li_erinacine_mild_AD_BDNF_not_NGF | LITERATURE | Human mild AD; erinacine A–enriched Hericium mycelia RCT 49 wk (Li 2020) | MMSE / IADL / neuroimaging signals; biomarkers include BDNF, Aβ1-40, apoE4, ACT — NGF not listed; no TrkA/NGF-block residual arm (PMID 32581767 / DOI 10.3389/fnagi.2020.00155) — BDNF pathway ≠ NGF mediation / ≠ residual H2H |
| Zhang_PC12_NGF_potentiation | LITERATURE | PC12; Hericium constituents ± NGF; neurite-bearing cells (Zhang 2015) | named constituents in presence of NGF increase neurite-bearing cells (PMID 26481911 / DOI 10.1016/j.bmcl.2015.10.016) — potentiation context; not residual under block that abolishes NGF-class gain |
| matched_residual_Hericium_under_NGF_TrkA_block_H2H | UNKNOWN | Same PC12 neurite panel — NGF-class positive control ± TrkA inhibitor / neutralizing NGF Ab + Hericium extract (or named hericenone/erinacine prep) ± same block; score residual Hericium neurite under block that abolishes NGF-class gain (± optional rodent cognitive overlay after cell lock) | dedicated residual-Hericium under NGF/TrkA block that abolishes NGF-class gain not found (soft-complete 0 true co-panel; NON-MATCH potentiation/pathway 28758954/25288148/33066380; anti-NGF ∩ Hericium = 0; Mori/Li ∩ block = 0) — UNKNOWN + missing_search |
| residual_Hericium_neurite_ge_50pct_of_alone_when_NGF_class_abolished | PREDICTION | Pre-registered PC12 neurite-outgrowth panel; NGF-class arm must show abolished neurite gain under NGF neutralization or TrkA blockade; Hericium arm scored for residual neurite vs Hericium-alone under the same block | residual Hericium neurite phenotype ≥50% of Hericium-alone (neurite-bearing % or neurite length units as pre-specified) while NGF-class neurite gain is abolished under the same NGF neutralization / TrkA block; α/N pre-specified — do not invent observed Δ or dosing |
| competing_block_fail_or_Hericium_null_or_underpowered_inconclusive | PREDICTION | Same design; competing outcomes if apparent residual failure/success is only failure of block to abolish NGF-class gain, Hericium-alone null, underpowered strata, or assay-identity mismatch (potentiation / NGF-deprivation ≠ residual-under-block) | block-fail-to-abolish / Hericium-alone-null / underpowered-strata / assay-mismatch allowed as pre-registered competing outcomes (inconclusive_if ≠ refute_if) — does not invent those results |
Ablate
- remove same PC12 neurite contrast of residual Hericium phenotype under NGF neutralization / TrkA blockade that abolishes NGF-class neurite gain: Without the abolish×residual H2H on a Zhang-class PC12 neurite panel with an NGF-class positive control, separate NGF-induction LITERATURE, cognition-without-NGF-PD LITERATURE, and NGF-potentiation LITERATURE cannot show ngf-insufficiency.
- remove verified abolish gate (NGF neutralization or TrkA block that abolishes NGF-class gain) plus Hericium-alone comparator as the residual gate: Without verified NGF-class abolish and Hericium-alone comparator under the same block, residual Hericium neurite is just “another neurotrophic extract under nonspecific block,” not an assumption-kill of NGF/TrkA-sufficiency for Hericium phenotype.
- remove N2≠N17 + N15≠N17 + N16≠N17 + N1–N16≠proof + soft-complete-empty≠novelty + potentiation≠residual-H2H + NOT-MB/MAOI + ip_class≠none discipline: Treating N2 open Q, N15 modafinil-DAT residual, N16 plasma-Cr/PCr, empty/adjacent PubMed, or Mori/Li/Zhang alone as already deciding residual Hericium under NGF/TrkA block would invent an H2H result left UNKNOWN.
Refute if
On the pre-registered PC12 neurite-outgrowth panel, under NGF neutralization or TrkA blockade that abolishes NGF-class neurite gain, residual Hericium neurite phenotype falls below 50% of Hericium-alone (neurite-bearing % or neurite length units as pre-specified) — so NGF/TrkA-sufficiency for Hericium neurite phenotype survives and ngf-insufficiency fails — when block-abolish, Hericium-alone comparator, and power/assay artifacts that would otherwise leave the test inconclusive are ruled out.
Ask a human
Lock PC12 neurite assay identity (neurite-bearing % / neurite length class), NGF-class positive-control abolish gate under named TrkA inhibitor or neutralizing NGF Ab, Hericium extract (or named hericenone/erinacine prep) alone comparator, and optional rodent cognitive overlay only after cell abolish×residual locks; do not treat N2 or N15 or N16 or N1–N16 as proof; no dosing; NOT MB/MAOI; not N15 DAT clone; not N16 creatine clone; do not burn ip_class=none.
Cheap IP
kill_cost_tier=1 · time_to_refute=4w · ip_class=ngf-insufficiency · vault_hold=no
Execution
execution_status=NOT_RUN · fto_status=UNKNOWN · related_prior=N2 (open Q ≠ matched residual H2H; holds sole ip_class=none); N15 (modafinil-DAT residual ≠ Hericium×NGF/TrkA); N16 (plasma-Cr/PCr ≠ Hericium×NGF/TrkA); N1–N16 ≠ proof
Swarm metadata
STATUS_LABEL: NEGATIVE openlabs_target: discussion openlabs_topic: neuroscience-brain tags: nootropics, brain-longevity risk_class: research-discussion polarity: negative card: ~/hypothesis-swarm/cards/N17.card.md card_sha256: f8163bebc6fc0582d24903d3a83de4585be4416e0e95c303c9873f393ccf4ec8
Mol Labs public report: PENDING dual-publish